日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Rhodopseudomonas palustris Uridylate kinase (pyrH) CSB-YP619785RAAG
CSB-EP619785RAAG
CSB-BP619785RAAG
CSB-MP619785RAAG
CSB-EP619785RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris LexA repressor (lexA) CSB-YP619786RAAG
CSB-EP619786RAAG
CSB-BP619786RAAG
CSB-MP619786RAAG
CSB-EP619786RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Enolase (eno) CSB-YP619787RAAG
CSB-EP619787RAAG
CSB-BP619787RAAG
CSB-MP619787RAAG
CSB-EP619787RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris 7-cyano-7-deazaguanine synthase (queC) CSB-YP619788RAAG
CSB-EP619788RAAG
CSB-BP619788RAAG
CSB-MP619788RAAG
CSB-EP619788RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris N utilization substance protein B homolog (nusB) CSB-YP619789RAAG
CSB-EP619789RAAG
CSB-BP619789RAAG
CSB-MP619789RAAG
CSB-EP619789RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Large-conductance mechanosensitive channel (mscL), partial CSB-YP619790RAAG1
CSB-EP619790RAAG1
CSB-BP619790RAAG1
CSB-MP619790RAAG1
CSB-EP619790RAAG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Sodium/potassium-transporting ATPase subunit alpha-4 (ATP1A4), partial CSB-YP619791HU
CSB-EP619791HU
CSB-BP619791HU
CSB-MP619791HU
CSB-EP619791HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Integrin alpha-9 (ITGA9), partial CSB-YP619792HU
CSB-EP619792HU
CSB-BP619792HU
CSB-MP619792HU
CSB-EP619792HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Leucyl/phenylalanyl-tRNA--protein transferase (aat) CSB-YP619793RAAG
CSB-EP619793RAAG
CSB-BP619793RAAG
CSB-MP619793RAAG
CSB-EP619793RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human General transcription factor IIH subunit 3 (GTF2H3) CSB-YP619794HU
CSB-EP619794HU
CSB-BP619794HU
CSB-MP619794HU
CSB-EP619794HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris N (2)-fixation sustaining protein CowN (cowN) CSB-YP619795RAAG
CSB-EP619795RAAG
CSB-BP619795RAAG
CSB-MP619795RAAG
CSB-EP619795RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Isopentenyl-diphosphate Delta-isomerase 1 (IDI1) CSB-YP619796HU
CSB-EP619796HU
CSB-BP619796HU
CSB-MP619796HU
CSB-EP619796HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human cGMP-dependent protein kinase 1 (PRKG1) CSB-YP619797HU
CSB-EP619797HU
CSB-BP619797HU
CSB-MP619797HU
CSB-EP619797HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Glutamate-ammonia-ligase adenylyltransferase (glnE), partial CSB-YP619798RAAG
CSB-EP619798RAAG
CSB-BP619798RAAG
CSB-MP619798RAAG
CSB-EP619798RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Urease accessory protein UreG (ureG) CSB-YP619799RAAG
CSB-EP619799RAAG
CSB-BP619799RAAG
CSB-MP619799RAAG
CSB-EP619799RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris NADH-quinone oxidoreductase subunit H 1 (nuoH1), partial CSB-YP619800RAAG
CSB-EP619800RAAG
CSB-BP619800RAAG
CSB-MP619800RAAG
CSB-EP619800RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Probable hydrogenase nickel incorporation protein HypA (hypA) CSB-YP619801RAAG
CSB-EP619801RAAG
CSB-BP619801RAAG
CSB-MP619801RAAG
CSB-EP619801RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP619802RAAG
CSB-EP619802RAAG
CSB-BP619802RAAG
CSB-MP619802RAAG
CSB-EP619802RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Ferrochelatase (hemH) CSB-YP619803RAAG
CSB-EP619803RAAG
CSB-BP619803RAAG
CSB-MP619803RAAG
CSB-EP619803RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopseudomonas palustris Argininosuccinate synthase (argG) CSB-YP619804RAAG
CSB-EP619804RAAG
CSB-BP619804RAAG
CSB-MP619804RAAG
CSB-EP619804RAAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×